Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03470012 · ClinicalTrials.gov registry record · NA

Adhesive Tape Trauma Evaluation of a New Gentle Tape in Healthy Infant Subjects

A NA study of Skin (FLACC Scores of Test Subjects) After Tape Removal, sponsored by Solventum US.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03470012 is a NA study of Skin (FLACC Scores of Test Subjects) After Tape Removal that has completed, run by Solventum US. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03470012, a NA study of Skin (FLACC Scores of Test Subjects) After Tape Removal, has completed, sponsored by Solventum US.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine the relative gentleness of a new medical tape.

Interventions

  • DEVICE Multi-Purpose Gentle Tape

Study Locations (1)

Pennsylvania

  • cyberDERM, inc. - Broomall

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-01-16
Est. Completion 2018-03-20
Phase NA

Sponsor

Solventum US

41 total trials

What the Registry Record Tells You About NCT03470012

The ClinicalTrials.gov registry entry for NCT03470012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin (FLACC Scores of Test Subjects) After Tape Removal appearing as the primary indexed condition, and to 1 intervention - of which Multi-Purpose Gentle Tape is the first listed.

NCT03470012 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03470012 about?

NCT03470012 is a clinical study titled "Adhesive Tape Trauma Evaluation of a New Gentle Tape in Healthy Infant Subjects". The objective of this study is to determine the relative gentleness of a new medical tape.

What is the current status of trial NCT03470012?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-01-16. Estimated completion is 2018-03-20.

What conditions does trial NCT03470012 study?

This clinical trial studies the following conditions: Skin (FLACC Scores of Test Subjects) After Tape Removal.

What interventions are being tested in trial NCT03470012?

The interventions under investigation include: Multi-Purpose Gentle Tape (DEVICE).

Who is sponsoring clinical trial NCT03470012?

This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03470012 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.